Lrmr news
Web7 apr. 2024 · Larimar Therapeutics Inc. (LRMR) shares are 42.36% up over the last 6 months, with its year-to-date growth rate higher than industry average at 21.17% against 13.40%. Revenue is forecast to grow 26.00% this quarter before jumping 38.80% for the next one. LRMR Dividends Larimar Therapeutics Inc. has its next earnings report out in … Web17 mrt. 2024 · LRMR has outperformed the market in the last year with a return of +26.0%, while the SPY ETF lost -9.5%. In the last 3 month period, LRMR beat the market returning +20.1%, while SPY returned +2.1%. However, in the most recent 2 weeks LRMR has underperformed the stock market by returning -14.1%, while SPY returned -3.1%.
Lrmr news
Did you know?
Web3 apr. 2024 · Volatility Over Time: LRMR's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of US stocks. About the Company Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Web14 mrt. 2024 · Larimar Therapeutics Inc - LRMR stock news. Get the latest stock news for Nasdaq companies, press releases, financial disclosures and multimedia content, for day traders, investment community, individual investors and the general public.
Web29 sep. 2024 · Sep 29, 2024. 0 Hypes. 5. LeBron James is committing to his love for pickleball with the acquisition of an official Major League Pickleball (MLP) team. Signing on with his business partner ... Web10 apr. 2024 · About LRMR Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell …
WebLarimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. Web4 apr. 2024 · (NASDAQ: LRMR) Larimar Therapeutics currently has 43,269,200 outstanding shares. With Larimar Therapeutics stock trading at $4.55 per share, the total value of …
Web12 apr. 2024 · Sell candidate since 2024-04-03 Loss -1.76% PDF. The Larimar Therapeutics, Inc. stock price gained 2.29% on the last trading day (Thursday, 6th Apr 2024), rising from $4.37 to $4.47. During the last trading day the stock fluctuated 6.95% from a day low at $4.30 to a day high of $4.60. The price has fallen in 5 of the last 10 days but …
Web7 feb. 2024 · BALA CYNWYD, Pa. , May 19, 2024 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company … liberty tax freeport nyWebLRMR closed down 0.89 percent on Monday, March 27, 2024, on 1.28 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. ... See more LRMR news... Comments * View full discussion... Indicators Indicator Value; 52 Week High: 6.85: 52 Week Low: 1.53: Average Volume: 194,680: 200-Day Moving Average: 3.57: 50 ... liberty tax gillette wyWeb1 apr. 2024 · In last trading session, Larimar Therapeutics Inc. (NASDAQ:LRMR) saw 1.32 million shares changing hands with its beta currently measuring 0.54. Company’s recent per share price level of $4.53 trading at $0.4 or 9.69% at ring of the bell on the day assigns it a market valuation of $192.48M. liberty tax ft myersWeb15 feb. 2024 · During the last check, the stock of LRMR declined 56.99% to $3.6, in the pre-market. The company filed the form SC 13G/A with the SEC, on February 14, 2024. The form refers. ... LRMR News: On February 14, 2024, the company provided the update on CTI-1601 clinical trials through a press release. liberty tax fort walton beachWeb14 mrt. 2024 · JMP Securities analyst Jonathan Wolleben reiterated a Buy rating on Larimar Therapeutics ( LRMR – Research Report) today and set a price target of $15.00. The company’s shares closed today at ... liberty tax grand junctionWeb30 mrt. 2024 · $LRMR Q2 guidance to move to 50mg. maybe Gugg conf next Tuesday we could get news that cleared to move to 50mg. Big deal if they can start 50mg dosing in April. liberty tax gladstone moWebLarimar (LRMR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall … liberty tax google review